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toxigenic Vibrio cholerae of the O139 serogroup have been responsible for several large cholera 
epidemics in South Asia, and continue to be of clinical and historical significance today. This serogroup 
was initially feared to represent a new, emerging V. cholerae clone that would lead to an eighth cholera 
pandemic. However, these concerns were ultimately unfounded. The majority of clinically relevant  
V. cholerae O139 isolates are closely related to serogroup O1, biotype El Tor V. cholerae, and comprise 
a single sublineage of the seventh pandemic El Tor lineage. Although related, these V. cholerae 
serogroups differ in several fundamental ways, in terms of their O-antigen, capsulation phenotype, 
and the genomic islands found on their chromosomes. Here, we present four complete, high-quality 
genomes for V. cholerae O139, obtained using long-read sequencing. Three of these sequences are from 
toxigenic V. cholerae, and one is from a bacterium which, although classified serologically as  
V. cholerae O139, lacks the CTXϕ bacteriophage and the ability to produce cholera toxin. We highlight 
fundamental genomic differences between these isolates, the V. cholerae O1 reference strain N16961, 
and the prototypical O139 strain MO10. These sequences are an important resource for the scientific 
community, and will improve greatly our ability to perform genomic analyses of non-O1 V. cholerae in 
the future. These genomes also offer new insights into the biology of a V. cholerae serogroup that, from 
a genomic perspective, is poorly understood.
Vibrio cholerae is the aetiological agent of cholera, an acute, life-threatening diarrhoea which has spread world-
wide in seven pandemics since the nineteenth century. V. cholerae is typically sub-classified into serogroups on 
the basis of its somatic O-antigen. Despite there being over 200 serogroups of V. cholerae1,2, only serogroup O1 
has caused large scale epidemics historically3. Previous cholera pandemics have been caused by the classical bio-
type of V. cholerae O1, whereas the ongoing seventh pandemic, which began in the 1960s, is caused by the El Tor 
biotype of V. cholerae O13,4. Non-O1 serogroups of V. cholerae do not appear to cause pandemics, though they 
may cause outbreaks of disease. This is exemplified by an outbreak in Sudan in 1968, caused by V. cholerae O37, 
which was subsequently found to be genetically related to pandemic V. cholerae O15–8.
In 1992, a V. cholerae clone of serogroup O139 caused a large cholera epidemic which spread rapidly across 
Bangladesh and India9,10. Due to the geographic location of the epidemic, this clone was given the name Vibrio 
cholerae O139 Bengal10 (dubbed V. cholerae O139 hereafter). V. cholerae O139 caused substantial numbers of 
cholera cases in Southeast Asia in the early 1990s, and was anticipated to emerge as the aetiological agent of 
an eighth cholera pandemic11–13. However, rather than causing a pandemic, V. cholerae O139 was associated 
only with a low-level incidence of cholera cases after the initial 1992–93 epidemic, until a second large outbreak 
occurred in Bangladesh in the Spring of 200214. The re-emergence of this serogroup renewed fear that an eighth 
pandemic of cholera was beginning, driven by V. cholerae O13915. Once again, V. cholerae O139 did not proceed 
to cause a cholera pandemic, and although it no longer appears to be causing epidemic cholera, this serogroup has 
continued to be isolated since 2002. Recently, non-toxigenic V. cholerae O139 have been isolated in Thailand16. 
Toxigenic V. cholerae O139 have been isolated in China as recently as 201317, and continue to be isolated in 
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Bangladesh. Six V. cholerae O139 strains were isolated in Bangladesh between 2013 and 201418 (four included in 
this analysis), and three more strains were isolated between 2015 and 2017.
Despite the low incidence of cholera caused by V. cholerae O139, this serogroup continues to be important to 
both the research and public health communities, not least because the disease caused by V. cholerae O139 is clin-
ically indistinguishable from that caused by V. cholerae O110. Accordingly, V. cholerae O139 continues to be the 
subject of surveillance in Southeast Asia and is included in cholera vaccine formulations19–21. Early genetic and 
biochemical studies demonstrated that O139 strains were closely related to O1 seventh pandemic El Tor strains, 
and it was suggested that V. cholerae O139 had arisen from an O1 El Tor ancestor9,22–24. This was subsequently 
confirmed using whole-genome sequencing, which showed that toxigenic V. cholerae O139 formed a discrete 
sub-lineage within the seventh pandemic El Tor (7PET) lineage25,26.
Although the clinical diseases caused by V. cholerae O1 and O139 are indistinguishable, there are notable 
differences between V. cholerae O139 and V. cholerae O1 in addition to their serogroup. For instance, V. cholerae 
O139 expresses a polysaccharide capsule, which 7PET V. cholerae O1 isolates lack27. The capsule is encoded by 
genes not found in other 7PET V. cholerae O1 genomes, which are located adjacent to the locus encoding lipopol-
ysaccharide (LPS) biosynthesis genes in V. cholerae O13915,28–32. It has also been reported that the complement 
of genomic islands found in the genome of MO10, a V. cholerae O139 strain, differs from that found in 7PET 
V. cholerae O125. The MO10 genome sequence is currently used to represent V. cholerae O139 in comparative 
genomic analyses, but its genome sequence is incomplete and comprises 84 contigs (assembly accession number 
GCA_000152425.1).
V. cholerae O139 caused 93% of laboratory-confirmed cholera cases in China in the early 2000s19. Such data 
demonstrate why V. cholerae O139 has twice been feared to be responsible for an eighth cholera pandemic. 
Despite the clinical importance of this serogroup which continues to be isolated today, a closed reference genome 
for V. cholerae O139 has not yet been published. Here, we report the first high-quality, closed reference genome 
sequences for this V. cholerae serogroup. We have used long-read sequencing to obtain the complete genome 
sequences of four recent V. cholerae O139 isolates from Bangladesh18. Three of these are toxigenic members of 
the 7PET lineage, two of which were isolated from asymptomatic patients from within a household where there 
had been a confirmed cholera case. The fourth isolate was acquired from a patient suffering from diarrhoea, 
vomiting and dehydration (see ref.18 for full details of the clinical history surrounding these four isolates), but is a 
non-toxigenic V. cholerae O139 variant that is not part of the 7PET lineage, and does not harbour the CTXϕ bac-
teriophage18. This non-7PET genome offers an opportunity to study the genetic factors that enable non-toxigenic 
V. cholerae to cause diarrhoea in patients.
Results
Structure of CTXϕ tandem arrays in V. cholerae O139. Using long-read sequencing read data, we gen-
erated single, contiguous genome sequences for the two chromosomes of each isolate sequenced in this study. Use 
of the corresponding short-read data for each isolate to correct these assemblies did not improve the assemblies. 
None of these isolates contained a third replicon, as has been reported elsewhere in other V. cholerae33. In order 
to estimate genetic distance, we mapped each sample’s corresponding short-read data18 to the 7PET reference 
genome N16961 and called single nucleotide variants (SNVs) between the mapped reads for these isolates and 
N16961. These SNV data are provided in Table 1, together with summary statistics for these closed assemblies. 
Since the three toxigenic samples were found to have near-identical genomes, varying in size by 4 bases at most, 
and differing by fewer than five SNVs between one another (SNVs were determined relative to N16961), 48853_
H01 was selected as an exemplar sequence for further analyses.
The CTXϕ bacteriophage integrates into the V. cholerae chromosome in a XerCD-dependent manner, 
by recombination between the CTXϕ attP site and bacterial attB site, which produces hybrid attL and attR 
sequences34,35. This occurs after the replicative, circular form of the viral genome forms after infection of the 
cell, and this integration usually involves tandem integrations of CTXϕ into the genome36. CTXϕ replication is 
achieved by the production of ssDNA from chromosomal tandem arrays of CTXϕ in a manner dependent on 
the CTXϕ-encoded RstA protein, where RstA nicks the CTXϕ replication origin located in the intergenic region 
Ig-136,37. The exposed 3′ site permits synthesis of CTXϕ DNA up until the second, tandem CTXϕ replication 
origin is encountered, which is also a substrate for RstA cleavage, creating a free CTXϕ genome36,37. We observed 
Internal 
sequence ID 
(PacBio) Sample Name CTXϕ present?
Accession 
(PacBio reads)
Accession (closed 
chromosomal 
assembly)
Accession 
(Illumina 
reads)
Genome 
Size (bp)
Average 
coverage of de 
novo assembly 
with long 
reads (X)
Coverage 
of N16961 
(%)
Number 
of SNVs 
relative to 
N16961
48853_F01 MP_070116 No ERR1716489 LT992490-LT992491 ERR568405 4123525 165.76 58.5 122865
48853_G01 P_0684000 Yes ERR1716490 LT992486-LT992487 ERR568406 4092641 170.56 97 271
48853_H01 ICVB_2236_02 Yes ERR1716491 LT992488-LT992489 ERR568407 4092645 147.29 97 270
48853_A02 SMIC_67_01 Yes ERR1716492 LT992492-LT992493 ERR568408 4092644 165.65 97 274
Table 1. Summary of the V. cholerae O139 genome assemblies generated in this study. The accession numbers 
for both the long-read sequences and assemblies generated in this study, and the original short reads used 
for assembly polishing, SNV calling, and phylogenetic analyses (see Methods) are reported. The SNV counts 
reported do not account for the removal of recombinogenic sequences, since the non-toxigenic isolate was not 
included in the recombination analysis. Average coverage values taken from de novo HGAP assemblies.
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two additional CTXϕ bacteriophage sequences in tandem, relative to that found in the N16961 reference genome, 
located between VC_1450 and VC_1467 in the larger chromosome in the three toxigenic isolates (Fig. 1). A 
partial third repeat of CTXϕ was evident, comprising the genes between and including zot and rstA, and an 
rstR open reading frame corresponding to rstRCalc 38 (Fig. 1). We identified a complete attL sequence adjacent to 
the VC_1465 locus in 48853_H0135. The phage sequence in the attR site adjacent to rtxA is not identical to that 
reported by Huber and Waldor35, although the attR sequence does contain both the central recombination iden-
tity sequence and the residual bacterial attB sequence.
Although tandem repeats of CTXϕ genes in V. cholerae O139 have been reported previously15,38,39, difficulty in 
assembling these repetitive regions with short-read sequencing data meant that these repeats were not identified 
in our original sequencing of these isolates18. We mapped the short-read data to the long-read assemblies for each 
of these genomes, and to the N16961 reference, to confirm that short reads mapped to both the ctxB4 and ctxB5 
variant CTXϕ regions, and that when mapped to N16961, the coverage of the CTXϕ region was approximately 
double that of the surrounding chromosome (Supplementary Fig. S1). Manual inspection of these mapping data 
showed that reads from both ctxB alleles mapped to the N16961 ctxB locus.
We noted that the two ctxB genes in these genomes are of different alleles (Fig. 1). The ctxB gene closest to 
rtxA in these assemblies was a ctxB4 allele, and the second ctxB was a ctxB5 allele. Both of these are ctxB alleles 
that have been found in V. cholerae O139 strains previously40,41. The presence of more than one ctxB allele in the 
same V. cholerae genome has not been reported previously to our knowledge, though it has been reported that V. 
cholerae O139 can harbour more than one type of CTXϕ phage simultaneously15,38,42.
Genomic islands and antimicrobial resistance genes in V. cholerae O139. Having observed these 
unusual CTXϕ configurations, we scanned the four assemblies for the presence and absence of the genomic 
islands that are associated with pandemic V. cholerae: VSP-1, VSP-2, VPI-1, VPI-2, and the drug resistance 
genetic element SXT25. We identified VPI-1 and VSP-2 islands in all three of the toxigenic V. cholerae O139 
isolates, and we confirmed that VPI-2 is severely truncated to the point of absence, as described previously for 
MO1025,43 (Fig. 2). We identified a genomic island integrated into the VC_0659 locus (encoding peptide chain 
release factor 3) in each of the three toxigenic V. cholerae O139 assemblies, identical to SXT, which is also known 
as ICEVchInd444. SXT is integrated into the same locus as it is in MO10. We also identified an insertion into 
VC_0659 in the non-toxigenic genome assembly, which was 64% identical to ICEVchInd4 (Table 2). All of these 
observations agree with data from Chun et al.25 on the distribution of genomic islands in the V. cholerae O139 
MO10 genome.
In the three toxigenic V. cholerae O139 isolates, we detected the VSP-1 element integrated on the larger chro-
mosome between genes VC_0173 and VC_0187, as found in N1696125 (Fig. 2). However, we also observed a 
sequence of DNA on the smaller chromosome of each of the toxigenic isolates, integrated between VC_A0695 and 
VC_A0696, that was 99% identical to VSP-1 (VC_0175 to VC_0186; Supplementary Fig. S2). This suggested that a 
second copy of the VSP-1 element was present on the second chromosome in each of these genomes. We mapped 
the previously-published Illumina reads for these genomes18 to the N16961 reference genome and plotted the 
read depth for VSP-1 relative to the surrounding genome (Supplementary Fig. S2), which further supported the 
conclusion that these genomes contain a second copy of VSP-1.
This VSP-1 duplication was detected in each of the three toxigenic V. cholerae O139 genome assemblies (sum-
marised in Table 2). It is known that VSP-1 is capable of excising from the larger V. cholerae chromosome45, and 
it has been previously reported that the Matlab variant V. cholerae O1 strain MJ-1236 harbours a second copy of 
VSP-1 integrated between VC_A0695 and VC_A069646. Grim et al.46 used PCR to identify a single clinical isolate 
of V. cholerae O139 from Bangladesh that harboured an insertion between VC_A0695 and VC_A0696 resembling 
VSP-1, but this isolate was not described further. This phenomenon is likely to be that which we have now con-
firmed to be present in these three V. cholerae O139 genomes.
Figure 1. Tandem copies of the CTXϕ bacteriophage in V. cholerae O139. An illustration of the genomic 
organisation of three tandem copies of CTXϕ in the toxigenic V. cholerae O139 samples in this study. Two 
copies of the ctxAB operon are present in these genomes, which harbour different ctxB alleles to one another 
and to that of N16961. Exemplar data from the assembly for 48853_H01 are presented. Loci are not to scale. 
Figure annotation based on ref.36.
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We also compared the genomic island complement of these four sequences with that of MO10. MO10 har-
bours a kappa prophage (GI-1125), which is absent from N16961 and also absent from the four sequences in this 
study (Supplementary Fig. S3). Likewise, MO10 harbours the Vibrio VSK prophage (GI-1625), which is absent 
from both N16961 and the O139 sequences in this study (Supplementary Fig. S3). MO10 does not appear to 
harbour the second VSP-1 copy on chromosome 2 which we identified in the three toxigenic isolates. The SXT 
variant harboured by MO10 is expanded relative to that found in these strains (Supplementary Fig. S3), and 
this expansion includes genes conferring resistance to the antimicrobials streptomycin (strAB), sulfamethoxazole 
(sul2), trimethoprim (dfr18), and chloramphenicol (floR). We scanned the assemblies for the four O139 genomes 
for antimicrobial resistance genes. The non-toxigenic 48853_F01 genome does not harbour any known anti-
microbial resistance genes. The three toxigenic O139 genomes also do not contain any antimicrobial resistance 
genes, though they do harbour a catB9 gene that is known not to confer antibiotic resistance47. These data are con-
cordant with the original antimicrobial sensitivity testing of these isolates, which found that they were resistant 
only to nalidixic acid18. We confirmed that these four isolates harbour an S83I mutation in GyrA, and that 48853_
F01 also contains an A171S mutation in GyrA and a S85L mutation in ParC. All of these mutations are associated 
with nalidixic acid resistance in V. cholerae48. We also scanned the assembled genomes of the four isolates for the 
presence of V. cholerae accessory virulence genes, to determine whether candidate virulence genes were present 
in the genome of the otherwise non-toxigenic V. cholerae O139 isolate18 (Table 3). We did not identify any viru-
lence determinants in the 48853_F01 genome assembly other than those typically found in V. cholerae3.
Figure 2. BLAST atlas comparing the genomes used in this study and MO10 to the N16961 reference genome. 
The presence of VPI-1, VSP-1, and VSP-2 in the three toxigenic V. cholerae O139 assemblies, as well as the 
truncation of VPI-2, is indicated. The non-toxigenic strain did not harbour VSP-1, VSP-2, or VPI-2 (indicated), 
although a region homologous to part of VPI-1 (VC_0809 to VC_0816) was detected on the larger chromosome. 
The sequences of both V. cholerae chromosomes were concatenated to generate this figure; the boundary 
between the chromosomes is denoted.
Sample 
Name VSP-1 (VC_0174-VC_0186)
VSP-2 (VC_0489-
VC_0517) VPI-1 (VC_0809-VC_0848)
VPI-2 (VC_1757-
VC_1810)
CTXϕ (VC_1451-
VC_1465)
SXT (VC_0659 
insertion)
48853_F01 Absent Absent
Partially present (VC_0809-
VC_0816; deletion of 
VC_0817-VC_0848)
Absent Absent 64% match to ICEVchInd4
48853_G01 Present, and duplication of VC_0175–0186 on chr2 Present Present
Deletion of 
VC_1761–1787
Present, in more 
than one copy
100% match to 
ICEVchInd4
48853_H01 Present, and duplication of VC_0175–0186 on chr2 Present Present
Deletion of 
VC_1761–1787
Present, in more 
than one copy
100% match to 
ICEVchInd4
48853_A02 Present, and duplication of VC_0175–0186 on chr2 Present Present
Deletion of 
VC_1761–1787
Present, in more 
than one copy
100% match to 
ICEVchInd4
Table 2. Presence and absence of selected genomic islands in V. cholerae O139 genome assemblies. Similarity 
percentages were obtained by comparing SXT element sequences to that of ICEVchInd4 using BLASTn. 
chr2 = chromosome 2.
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phylogenetic analysis. We constructed a maximum-likelihood phylogeny from an alignment of core genes 
from 65 diverse V. cholerae genomes, and confirmed that despite its serogroup, 48853_F01 is not a member of the 
7PET O139 sublineage (Fig. 3A). We did find that the three toxigenic genomes were members of 7PET, and we 
used the previously-published short-read data for these genomes to place these isolates into phylogenetic context 
with 114 other V. cholerae, including 23 O139 genome sequences16,18,26 (117 genomes in total; Supplementary 
Table S1). We found that the three toxigenic isolates in this study clustered together with other 7PET V. cholerae 
O139 sequences from Bangladesh and India from 1992 to 2002 (Fig. 3B). The closest relatives of these three 
strains, which were isolated in 2013 and 2014, were isolated from Bangladesh in 2002 (A383, Case_09–12). All of 
these were also closely related to V. cholerae O139 samples from 1992–1995, including a recently-sequenced col-
lection of V. cholerae O139 from Thailand16. These results recapitulate and reinforce previously-published data18, 
adding to the utility of these genomes as reference sequences for toxigenic V. cholerae O139. Moreover, there are 
no complete genome assemblies for non-toxigenic V. cholerae O139. Given that this isolate is clearly distinct from 
the 7PET O139 sublineage, we anticipate that this genome sequence will enable comparative genomic studies of 
V. cholerae other than 7PET isolates.
The previous report of these genome sequences, obtained using short-read technology alone, examined 
the structure of the capsule and lipopolysaccharide (LPS) synthesis loci. These analyses were performed using 
incompletely-assembled genome sequences18. We used the closed sequences obtained in this project to compare 
these loci across the strains in this study to N16961 and MO10 (Supplementary Fig. S4). We confirmed that the 
three toxigenic strains contain O139 LPS operons that strongly resemble that found in MO10 (Supplementary 
Fig. S4). The equivalent region in the non-toxigenic isolate 48853_F01 is less similar, although this strain exhibits 
a strong O139-positive phenotype using the rapid dipstick assay and slide agglutination tests18. In our phyloge-
netic analyses, we noted that 48853_F01 clustered with two Haitian non-O1 V. cholerae isolates from 2010 and a 
Mexican isolate from 1991 for which there are no serotype data (Fig. 3A; Supplementary Table S1). We found that, 
although these three non-O1 V. cholerae share capsule biosynthesis genes with 48853_F01, they do not harbour 
the same LPS operon (Supplementary Fig. S4). These Haitian and Mexican isolates therefore are unlikely to be V. 
cholerae of serogroup O139.
Discussion
It is essential to have complete and accurate reference sequences to perform bacterial genomic analysis. Although 
several studies have provided closed V. cholerae sequences49–53, none to date have provided reference sequences 
for V. cholerae O139. The sequences in this study will serve as an important community resource in future studies 
of V. cholerae genomics and phylogenetics. For example, access to the closed sequences of the O139 LPS and cap-
sule biosynthesis operons from these four strains means that it should be possible to serotype V. cholerae O139 
sequences in silico. The fact that the LPS biosynthesis loci in these toxigenic and non-toxigenic strains are similar 
but not identical (Supplementary Fig. S4), and that the non-toxigenic strain is distantly related to the toxigenic V. 
cholerae O139 in this study (Fig. 3), suggests that there may be more than one genetic configuration that confers 
an O139 serogroup phenotype. In the absence of candidate virulence genes, putative or otherwise, we also can-
not exclude the possibility that the non-toxigenic isolate was obtained from a patient who was co-infected with 
another toxigenic organism such as enterotoxigenic Escherichia coli54–56.
Many of the observations in this study could only be made because of the resolution offered by long-read 
sequencing. For example, the observation that several ctxB alleles can co-exist in a single genome is striking. 
The co-existence of several CTXϕ sequences in tandem has been reported before, such as in the O395 classical 
reference sequence52,57 and in the PA1849 second-pandemic classical isolate4. However, in PA1849, the tandem 
bacteriophages are of the same ctxB allele, and in O395, the CTXϕ array on the larger chromosome consists of 
one intact CTXϕ and one partial prophage sequence57. Although these V. cholerae O139 had been sequenced pre-
viously, it had not been possible to assemble these genomes fully with the short-read Illumina technology used at 
the time. Consequently, in all three assemblies, CTXϕ was not assembled into a single contig, and only one of the 
two ctxB genes was identifiable (our Illumina assemblies for 48853_G01 and 48853_H01 contain a ctxB4 allele in 
Accessory virulence gene (N16961 locus ID or accession number)
Present in 
48853_F01
Present in 
48853_G01
Present in 
48853_H01
Present in 
48853_A02
ToxR (VC_0984) Yes Yes Yes Yes
Zona occludens toxin, Zot (VC_1458) No Yes Yes Yes
Accessory cholera enterotoxin, Ace (VC_1459) No Yes Yes Yes
Haemolysin, hlyA (VC_A0219) Yes Yes Yes Yes
Mannose-sensitive haemagglutinin, MSHA (VC_0398..VC_0414) Yes Yes Yes Yes
MARTX toxin, rtxA (VC_1451) Yes Yes Yes Yes
MARTX toxin accessory gene, rtxC (VC_1450) Yes Yes Yes Yes
HA/protease, hapA (VC_A0865) Yes Yes Yes Yes
Heat-stable enterotoxin NAG-ST (Accession # M85198.1) No No No No
Type III secretion system from V. cholerae AM_19226 (typically 
present in lieu of VPI-2; accession # AATY01000000) No No No No
Table 3. Presence and absence of accessory virulence genes in V. cholerae O139 genome assemblies. Gene 
presence and absence was determined using ACT67 to visualise BLASTn synteny plots, and using tBLASTx to 
scan assemblies using the NAG-ST nucleotide sequence as a query.
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a small contig, and 48853_A02 contains ctxB5 in a larger contig). In future studies of V. cholerae O139, mapping 
sequencing reads against these reference sequences will address this problem, which will not be resolved if data 
are exclusively mapped to N16961 or related sequences.
Furthermore, we note that the oligonucleotides used for PCR based ctxB typing40 are 100% homologous to 
regions upstream and downstream of both ctxB loci in these three genomes. It would therefore not be possible 
to discriminate between ctxB types based on Sanger sequencing of these amplicons. This suggests that caution 
should be used in the interpretation of PCR-based ctxB typing data in the epidemiological study of cholera out-
breaks, particularly if this CTXϕ configuration is present in other V. cholerae lineages.
The functions of VSP-1 and VSP-2 are not fully understood, although it is well-accepted that these two 
genomic islands are found in V. cholerae which are members of the seventh pandemic25. It is known that DncV, 
encoded by VSP-1, represses V. cholerae chemotaxis58 and that repression of chemotaxis has been linked to 
improved intestinal colonisation by V. cholerae59. DncV is also known to be upregulated under conditions of 
gastrointestinal infection, in response to conditions that activate the ToxT transcription factor via the TarB small 
RNA which prevents the production of VPI-1-encoded VspR. It is interesting to speculate that the duplication 
of VSP-1 might further attenuate V. cholerae chemotaxis under colonisation conditions via a gene dosage effect, 
thereby modulating the ability of these V. cholerae O139 strains to colonise the intestine.
Here, by sequencing V. cholerae O139 using long-read technology, we have highlighted genomic features that 
emphasise the genetic distinctions between V. cholerae O139 and V. cholerae O1. We have identified differences 
between these recent strains, N16961, and MO10, the V. cholerae O139 strain used for previous comparative anal-
yses. We have also described unusual phenomena in V. cholerae O139 genome biology – namely, the co-existence 
Figure 3. Phylogenetic analysis. (A) A total of 168,476 variable sites from a core-gene alignment of 2,103 genes 
from 65 genomes were used to generate a maximum-likelihood phylogenetic tree of the V. cholerae species, 
rooted on Vibrio metoecus and Vibrio sp. RC586. Two genomes that are representative of the 7PET lineage were 
included. The non-toxigenic isolate 48853_F01 clustered together with other non-toxigenic, non-O1/O139 V. 
cholerae. (B) A maximum-likelihood phylogeny of the 7PET lineage constructed using 1,629 non-recombinant 
variable sites across 117 V. cholerae genomes, rooted on M66-2. The three toxigenic samples in this study 
clustered together with other toxigenic O139 genome sequences, all of which form a discrete sub-lineage within 
7PET. Hatch marks denote branches that were shortened artificially for illustrative purposes; an unedited tree 
is presented in Supplementary Fig. S5. Trees were also computed using an ascertainment bias correction model 
(see Methods). These are presented in Supplementary Fig. S6.
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of more than one ctxB allele, and the cross-chromosome duplication of VSP-1. There also appears to have been 
genetic changes within V. cholerae O139 that has occurred since its first identification in 1992, typified by the 
MO10 isolate. Given that V. cholerae O139 is a member of 7PET, has several characteristics of a sublineage with 
the potential to cause pandemic disease, and continues to be isolated in recent years, research into this serogroup 
should continue. These reference sequences enable such research, and as well as providing interesting insights into 
the genome structure of recent V. cholerae O139, these sequences are an important resource for future genomic 
studies of V. cholerae as a pathogen and as a species.
Methods
Isolates and sequences used in this study. Four previously-described V. cholerae O139 isolates18 were 
selected for re-sequencing on the PacBio RSII platform. A set of 178 genomes in addition to these were included 
in comparative genome analyses (182 genomes in total; Supplementary Table S1).
DNA isolation. Genomic DNA was prepared from 25 ml cultures of bacterial isolates grown overnight at 
37 °C in LB media. Cells were harvested by centrifugation and resuspended in 2.0 ml of 25% w/v sucrose in TE 
buffer (10 mM Tris pH 8.0, 1 mM EDTA pH 8.0). Nuclei Lysis Solution (Promega, #A7941, 6.0 ml) was added and 
samples were lysed by incubation at 80 °C for five minutes. Samples were mixed with proteinase K (250 μg/ml 
final concentration), RNase A Solution (Promega, #A797A, 15 μg/ml final concentration), EDTA pH 8.0 (25 mM 
final concentration) and aqueous SDS solution (0.3% final concentration). Mixtures were incubated on ice for two 
hours and then at 50 °C overnight. Following enzymatic treatment, TE buffer was added to each sample (12 ml 
final volume). DNA was then isolated by phenol-chloroform extraction. Nucleic acids were precipitated in abso-
lute ethanol, washed in ethanol (70% v/v), and resuspended in approximately 350 μl Tris (10 mM; pH 8.0). EDTA 
was omitted from the resuspension solution, to avoid interference with PacBio sequencing chemistry.
Long-read sequencing. SMRTbell libraries were created from approximately 10 μg DNA according to the 
manufacturer’s protocol (15 kb library size, no size selection). Long reads were generated by sequencing on the 
PacBio RSII platform using polymerase version P6 and C4 sequencing chemistry. Sequence reads were assembled 
using HGAP v360 of the SMRT analysis software v2.3.0. The fold coverage to target when picking the minimum 
fragment length for assembly was set to 30 and the approximate genome size was set to 3 Mbp. The HGAP 
assembler assembled the reads from sample 48853_G01 into three contigs. However, assembling this sample 
with Canu v1.161 produced an assembly of two contigs, one per chromosome, and this was used for subsequent 
analysis. Assemblies were circularised using Circlator v1.1.362 and the pre-assembled reads (also known as cor-
rected reads). The circularised assemblies were polished using the PacBio RS_Resequencing protocol and Quiver 
v1 of the SMRT analysis software v2.3.0. Automated annotation was performed using Prokka v1.1163 and genus 
specific databases from RefSeq64. Pilon v1.1965 did not identify any SNVs in any of the PacBio assemblies using 
the corresponding short-read data – accordingly, no short-read corrections were made to these assemblies. Raw 
sequencing reads and the genome assemblies described in this study have been deposited into the European 
Nucleotide Archive (Table 1; Supplementary Table S1).
Comparative genomics and BLAST atlas construction. The four annotated genome assemblies were 
compared to one another, and to the N16961 and MO10 reference genomes (see Supplementary Table S1 for 
accession numbers), using BLASTn66. These comparisons were visualised using ACT67 and by BLAST atlas com-
parison using the GView web server (https://server.gview.ca/).
Read alignment, SNV identification, and core gene alignment. Paired-end Illumina reads from 
116 7PET V. cholerae O1 and O139 samples, together with the M66-2 pre-pandemic strain (117 genomes 
in total; Supplementary Table S1), were mapped to the V. cholerae O1 El Tor N16961 reference genome (see 
Supplementary Table S1 for accession numbers) using SMALT v.0.7.4. Variable sites were identified using sam-
tools mpileup v0.1.19, with parameters “-d 1000 –DsugBf ”, and bcftools v0.1.1968. High quality SNVs were deter-
mined as previously described69, and putative recombinant regions were detected and filtered from the alignment 
using Gubbins70, to produce a final alignment of 1,629 SNVs.
Prokka-annotated assemblies for 63 non-7PET and two 7PET genomes63,71 were used to generate a 
species-level pan-genome using Roary72 with the following arguments: “-e–mafft -s -cd 97”. Poorly-aligned 
and gap-rich sites were removed from an alignment of 2,103 core gene sequences using trimAl v1.4.rev573 with 
the “-automated1” argument. A total of 168,476 variable sites were identified in the resultant alignment using 
SNP-sites v2.3.274.
phylogenetic analysis. Maximum likelihood phylogenetic trees were constructed using RAxML v8.2.875 
under the GTR model with the gamma distribution to model site heterogeneity (GTRGAMMA), using 500 
bootstrap replicates. An alignment composed of 1,629 non-recombinant variable sites was used to generate a 
reference-based 7PET phylogeny. An alignment of 168,476 variable sites from 2,103 core genes was used to gener-
ate a core-gene V. cholerae species phylogeny. Trees were also computed using the GTR + ASC model in IQ-Tree 
v1.5.576, optimised for an input containing no invariant nucleotides, and were supported by 5,000 ultrafast boot-
strap approximations and approximate likelihood ratio tests77–79. Phylogenetic trees were visualised using FigTree 
v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/) and the interactive tree of life (iTOL) v380.
Identification of antimicrobial resistance genes. Genome assemblies were scanned for the presence of 
antimicrobial resistance genes using the ResFinder web server v2.1 (https://cge.cbs.dtu.dk/services/ResFinder/)81.
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Data Availability
Sequencing reads generated during this project have been deposited into the European Nucleotide Archive (ENA; 
http://www.ebi.ac.uk/ena) under study accession number PRJEB14661. Assembled genome sequences have been 
deposited under accession numbers LT992486- LT992493. Sequence alignments, phylogenetic tree data, and oth-
er supporting information are available in Figshare (https://doi.org/10.6084/m9.figshare.6480266).
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